Abstract
(Abstracted from Prev Med 2022;159:107019) To prevent cervical cancer, vaccination against human papillomavirus (HPV) is recommended for adolescents aged 21 to 65 years and cervical cancer screening for women aged 21 to 65 years. The National Committee for Quality Assurance Healthcare Effectiveness Data and Information Set (HEDIS) evaluates managed care plan effectiveness of care for HPV vaccination and cervical cancer screening, allowing individual health plans to assess their preventive services performance rates compared with other plans.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
